NCT07650851

Clinical Study on the Efficacy and Safety of Nalfurafine Hydrochloride Orally Disintegrating Tablets in Treating Pruritus in Patients Undergoing Maintenance Hemodialysis

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-07-01Est. Completion: 2028-12-31

Enrollment target: 150 participants

Locations

Chinese PLA General Hospital, Beijing, Beijing Municipality, China

Contact

xiangmei Chenliping.8@163.com 01066935462

Other microbiome trials you might be interested in

Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aPPhase 4Recruiting

Pruritus ChronicKidney Diseases, ChronicRenal Insufficiency, ChronicUremia; ChronicPruritus Due to Systemic Disorder (Disorder)Pruritus Due to Hemodialysis

The goal of this clinical trial is to compare a new intravenous drug, Anruikefen, with a traditional oral medication, na…

Multiple LocationsEst. completion Dec 31, 2027

View Trial →

Health Belief Model-Based Education for Pruritus and Quality of Life in Hemodialysis PatientsCompleted

HemodialysisPruritus

This study evaluates the effect of a Health Belief Model (HBM)-based educational intervention on pruritus severity and p…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.